XML 32 R15.htm IDEA: XBRL DOCUMENT

Non-Current Assets	12 Months Ended
Dec. 31, 2024
Non-Current Assets
Non-Current Assets	7. Non-Current Assets As at December 31, 2024, the Company had non-current assets of $0.4 million, which comprised clinical trial deposits held by a contract research organization in relation to the Company’s Phase 1/2 clinical trials. As at December 31, 2023, the Company had non-current assets of $1.3 million, which was wholly attributable to clinical trial deposits.

Non-Current Assets

12 Months Ended

Dec. 31, 2024

7. Non-Current Assets

As at December 31, 2024, the Company had non-current assets of $0.4 million, which comprised clinical trial deposits held by a contract research organization in relation to the Company’s Phase 1/2 clinical trials. As at December 31, 2023, the Company had non-current assets of $1.3 million, which was wholly attributable to clinical trial deposits.